Claim CB200:
Some biochemical systems are irreducibly complex, meaning that the removal
of any one part of the system destroys the system's function.  Irreducible
complexity rules out the possibility of a system having evolved, so it
must be designed.
Source:
Behe, Michael J. 1996. Darwin's Black Box, New York: The Free Press.
Response:
-  Irreducible complexity can evolve.  It is defined as a system that
   loses its function if any one part is removed, so it only indicates
   that the system did not evolve by the addition of single parts with no
   change in function.  That still leaves several evolutionary mechanisms:
 
 
-  deletion of parts
-  addition of multiple parts; for example, duplication of much or all
      of the system (Pennisi 2001)
-  change of function
-  addition of a second function to a part (Aharoni et al. 2004)
-  gradual modification of parts
 
 All of these mechanisms have been observed in genetic mutations.  In
   particular, deletions and gene duplications are fairly common (Dujon et
   al. 2004; Hooper and Berg 2003; Lynch and Conery 2000), and together
   they make irreducible complexity not only possible but expected.  In
   fact, it was predicted by Nobel-prize-winning geneticist Hermann Muller
   almost a century ago (Muller 1918, 463-464).  Muller referred to it as
   interlocking complexity (Muller 1939).
 
 Evolutionary origins of some irreducibly complex systems have been
   described in some detail.  For example, the evolution of the Krebs
   citric acid cycle has been well studied (Meléndez-Hevia et
   al. 1996), and the evolution of an "irreducible" system of a
   hormone-receptor system has been elucidated (Bridgham et al. 2006).
   Irreducibility is no obstacle to their formation.
 
 
-  Even if irreducible complexity did prohibit Darwinian evolution, the
   conclusion of design does not follow.  Other
 processes might
   have produced it.  Irreducible complexity is an example of a failed
   argument from incredulity.
 
 
-  Irreducible complexity is poorly defined.  It is defined in terms of
   parts, but it is far from obvious what a "part" is.  Logically, the
   parts should be individual atoms, because they are the level of
   organization that does not get subdivided further in biochemistry, and
   they are the smallest level that biochemists consider in their
   analysis.  Behe, however, considered sets of molecules to be individual
   parts, and he gave no indication of how he made his determinations.
 
 
-  Systems that have been considered irreducibly complex might not be.
   For example:
-  The mousetrap that Behe used as an example of irreducible complexity
     can be simplified by bending the holding arm slightly and removing the
     latch.
-  The bacterial flagellum is not irreducibly
 complex because
     it can lose many parts and still function, either as a simpler
     flagellum or a secretion system.  Many proteins of the eukaryotic
     flagellum (also called a cilium or undulipodium) are known to be
     dispensable, because functional swimming flagella that
     lack these proteins are known to exist.
-  In spite of the complexity of Behe's protein
 transport
     example, there are other proteins for which no transport is necessary
     (see Ussery 1999 for references).
-  The immune system example that Behe includes
 is not
     irreducibly complex because the antibodies that mark invading cells
     for destruction might themselves hinder the function of those cells,
     allowing the system to function (albeit not as well) without the
     destroyer molecules of the complement system.
 
Links:
TalkOrigins Archive. n.d.  Irreducible complexity and Michael Behe.
 http://www.talkorigins.org/faqs/behe.html
References:
-  Aharoni, A., L. Gaidukov, O. Khersonsky, S. McQ. Gould, C. Roodveldt
   and D. S. Tawfik. 2004.  The 'evolvability' of promiscuous protein
   functions.  Nature Genetics [Epub Nov. 28 ahead of print]
-  Bridgham, Jamie T., Sean M. Carroll and Joseph W. Thornton. 2006.
   Evolution of hormone-receptor complexity by molecular exploitation.
   Science 312: 97-101.  See also Adami, Christopher. 2006.  Reducible
   complexity.  Science 312: 61-63.
-  Dujon, B. et al. 2004.  Genome evolution in yeasts.
   Nature 430: 35-44.
-  Hooper, S. D. and O. G. Berg. 2003.  On the nature of gene innovation:
   Duplication patterns in microbial genomes.
   Molecular Biololgy and Evolution 20(6): 945-954.
-  Lynch, M. and J. S. Conery. 2000.  The evolutionary fate and
   consequences of duplicate genes.  Science 290: 1151-1155.  See also
   Pennisi, E., 2000.  Twinned genes live life in the fast lane.
   Science 290: 1065-1066.
-  Meléndez-Hevia, Enrique, Thomas G. Waddell and Marta
   Cascante. 1996.  The puzzle of the Krebs citric acid cycle: Assembling
   the pieces of chemically feasible reactions, and opportunism in the
   design of metabolic pathways during evolution.  Journal of Molecular
   Evolution 43(3): 293-303.
-  Muller, Hermann J. 1918.  Genetic variability, twin hybrids and
   constant hybrids, in a case of balanced lethal factors.  Genetics 3:
   422-499.  http://www.genetics.org/content/vol3/issue5/index.shtml
-  Muller, H. J. 1939. Reversibility in evolution considered from the
   standpoint of genetics.  Biological Reviews of the Cambridge
   Philosophical Society 14: 261-280.
-  Pennisi, Elizabeth. 2001.  Genome duplications: The stuff of evolution?
   Science 294: 2458-2460.
-  Ussery, David. 1999.  A biochemist's response to "The biochemical
   challenge to evolution".  Bios 70: 40-45.
   http://www.cbs.dtu.dk/staff/dave/Behe.html
 
Further Reading:
Gray, Terry M.. 1999. Complexity--yes! Irreducible--maybe! 
 Unexplainable--no! A creationist criticism of irreducible complexity. 
 http://tallship.chm.colostate.edu/evolution/irred_compl.html
 Lindsay, Don. 1996. Review: "Darwin's black box, the biochemical challenge
 to evolution" by Michael Behe. 
 http://www.don-lindsay-archive.org/creation/behe.html
 Miller, K. 1999.  Finding Darwin's God.  Harper-Collins, chap. 5.
Shanks, N. and K. H. Joplin. 1999. Redundant complexity: A
 analysis of intelligent design in biochemistry. Philosophy of Science
 66: 268-298.
 http://www.asa3.org/ASA/topics/Apologetics/POS6-99ShenksJoplin.html
Ussery, David. 1999.  (see above)
created  2001-2-17, modified  2007-7-19